Healthcare - Biotechnology - NASDAQ - US
$ 0.9752
-8 %
$ 353 M
Market Cap
-1.27
P/E
INCOME STATEMENT
1.2 M
REVENUE
-172 M
OPERATING INCOME
-177 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Lexicon Pharmaceuticals, Inc.
| Revenue | 1.2 M |
| Cost Of Revenue | 85 K |
| Gross Profit | 1.12 M |
| Operating Expenses | 173 M |
| Operating Income | -172 M |
| Other Expenses | 5.37 M |
| Net Income | -177 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||
| Revenue | 1.2 | 0.1 | 0.3 | 24.0 | 322.1 | 63.2 | 90.3 | 83.3 | 130.0 | 22.9 | 2.2 | 1.1 | 1.8 | 4.9 | 10.7 | 32.3 | 50.1 | 72.8 | 75.7 | 61.7 | 42.8 | 35.2 | 305.6 | 14.5 | 4.7 |
| GROSS PROFIT | |||||||||||||||||||||||||
| Cost Of Revenue | 85 K | 0.4 | 55.0 | 1.9 | 3.2 | 2.5 | 1.9 | 164.0 | 95.2 | 89.3 | 89.7 | 82.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2.6) | (2.0) |
| Gross Profit | 1.1 | (0.3) | (54.7) | 22.1 | 318.8 | 60.7 | 88.4 | (80.6) | 34.8 | (66.4) | (87.5) | (81.5) | 1.8 | 4.9 | 10.7 | 32.3 | 50.1 | 72.8 | 75.7 | 61.7 | 42.8 | 35.2 | 305.6 | 17.1 | 6.7 |
| OPERATING INCOME | |||||||||||||||||||||||||
| Operating Expenses | 172.9 | 100.9 | 87.4 | 200.9 | 148.8 | 164.0 | 223.0 | 221.2 | 119.0 | 108.7 | 106.8 | 99.6 | 115.9 | 100.6 | 100.7 | 128.9 | 125.1 | 128.0 | 111.8 | 109.2 | 105.4 | 98.1 | 349.2 | 52.6 | 19.5 |
| Selling, General and Administrative Expenses | 114.0 | 48.1 | 32.3 | 47.2 | 56.8 | 63.8 | 66.2 | 43.0 | 23.8 | 19.4 | 17.1 | 17.0 | 17.4 | 22.6 | 19.4 | 20.3 | 20.7 | 21.3 | 18.2 | 18.6 | 23.2 | 23.2 | 20.9 | 18.3 | 2.9 |
| Research and Development Expenses | 58.9 | 52.8 | 55.0 | 153.6 | 91.9 | 100.2 | 156.8 | 178.2 | 95.2 | 89.3 | 89.7 | 82.6 | 91.8 | 75.3 | 81.2 | 108.6 | 104.3 | 106.7 | 93.6 | 90.6 | 82.2 | 74.9 | 53.4 | 31.6 | 14.6 |
| Operating Income | (171.8) | (100.8) | (87.1) | (178.8) | 141.4 | (103.3) | (136.7) | (137.2) | 1.5 | (100.4) | (102.4) | (108.4) | (114.1) | (95.7) | (90.0) | (96.5) | (75.0) | (55.2) | (36.1) | (47.5) | (62.6) | (62.9) | (43.6) | (35.5) | (12.8) |
| PRE-TAX INCOME | |||||||||||||||||||||||||
| Interest Income Expense | 13.1 | 2.8 | 0.8 | 14.5 | 20.7 | 20.8 | 7.0 | 6.6 | 6.7 | 2.3 | 2.0 | 2.1 | 2.5 | 2.7 | 3.0 | 2.7 | 2.8 | 3.3 | 3.3 | 2.7 | 0.3 | 7 K | 0.3 | 0.4 | 0 |
| Total Other Income | (5.4) | (1.2) | (0.7) | (10.8) | (17.3) | (17.3) | (5.0) | (4.3) | (6.2) | 2 K | (1.8) | (1.8) | (2.1) | (6.1) | (3.5) | (0.3) | 3.7 | 0.8 | 77 K | 0.3 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Income | (177.1) | (101.9) | (87.8) | (58.6) | 124.1 | (120.5) | (141.7) | (141.4) | (4.7) | (100.4) | (104.1) | (110.2) | (116.2) | (101.8) | (93.4) | (96.9) | (71.2) | 54.4 | 39.2 | (46.1) | 0 | 0 | 0 | 0 | 0 |
| NET INCOME | |||||||||||||||||||||||||
| Tax Provision | 0 | 1.2 | 0.5 | 11.6 | (6.0) | 3.5 | (12.7) | 4.5 | 6.0 | 70 K | (0.8) | (2.0) | (2.4) | 26 K | (0.1) | (19.7) | (16.2) | (0.1) | 0.1 | (0.3) | 1.6 | (3.2) | (8.5) | (9.5) | (0.3) |
| Net Income | (177.1) | (103.1) | (88.3) | (70.2) | 130.1 | (120.5) | (129.1) | (141.4) | (4.7) | (100.3) | (104.1) | (110.2) | (116.2) | (101.8) | (82.8) | (76.9) | (58.8) | (54.3) | (36.3) | (47.2) | (64.2) | (59.7) | (35.2) | (26.0) | (12.5) |
| EPS | 0.8 | 0.62 | 0.61 | 0.63 | 1.23 | 1.14 | 1.23 | 1.36 | 0.0452 | 1.31 | 1.42 | 1.58 | 2.39 | 2.35 | 3.98 | 3.93 | 4.12 | 5.68 | 3.97 | 5.21 | 7.91 | 7.99 | 4.9 | 4.37 | 3.57 |